The Role of Glioma Microenvironment in Immune Modulation: Potential Targets for Intervention

Author(s): Mahua Dey, S. Farzana Hussain, Amy B. Heimberger

Journal Name: Letters in Drug Design & Discovery

Volume 3 , Issue 7 , 2006

Become EABM
Become Reviewer
Call for Editor


Malignant gliomas are associated with poor prognoses despite surgical, radiation and chemotherapy interventions. Since notable side-effects are associated with each of the aforementioned therapies, the future design of glioma immunotherapy clinical trials will need to address immune modulation at multiple levels for efficacious results. The review discusses emerging data that provides novel insights into immune modulation and their possible implications for immunotherapeutic approaches. The next generation of immunotherapy is largely focused on improving immune effector targeting and directing the tumor immune microenvironment to work synergistically with systematic immune activation.

Keywords: Microglia, Antigen presenting cells, Glioblastoma multiforme, Dendritic cell, Regulatory T cell, Central nervous system

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Published on: 01 March, 2012
Page: [443 - 453]
Pages: 11
DOI: 10.2174/157018006778194844
Price: $65

Article Metrics

PDF: 4